One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults
Sameed Ahmed M. Khatana, MD, MPH1,2,3; Atheendar S. Venkataramani, MD, PhD3,4; Ashwin S. Nathan, MD1,2,3; Elias J. Dayoub, MD, MPP2,3; Lauren A. Eberly, MD, MPH1,2,3; Dhruv S. Kazi, MD, MSc, MS5,6,7; Robert W. Yeh, MD, MSc5,6,7; Nandita Mitra, PhD3,8; S. V. Subramanian, PhD9; Peter W. Groeneveld, MD, MS2,3,10,11
doi : 10.1001/jama.2020.26141
JAMA. 2021;325(5):445-453
After a decline in cardiovascular mortality for nonelderly US adults, recent stagnation has occurred alongside rising income inequality. Whether this is associated with underlying economic trends is unclear.
Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin
Martin Ebinger, MD1,2; Bob Siegerink, PhD1; Alexander Kunz, MD1,2; Matthias Wendt, MD3; Joachim E. Weber, MD4,8; Eugen Schwabauer, MD5; Frederik Geisler, MD4; Erik Freitag, MD4; Julia Lange, MD4; Janina Behrens, MD4; Hebun Erdur, MD4; Ramanan Ganeshan, MD4; Thomas Liman, MD4; Jan F. Scheitz, MD1,4; Ludwig Schlemm, MD1,4; Peter Harmel, MD4; Katja Zieschang, MD3; Irina Lorenz-Meyer, MSc4; Ira Napierkowski, Dr rer nat4; Carolin Waldschmidt, MD4,6; Christian H. Nolte, MD1,4,7,8; Ulrike Grittner, DrPhil7,9; Edzard Wiener, MD10; Georg Bohner, MD10; Darius G. Nabavi, MD5; Ingo Schmehl, MD3; Axel Ekkernkamp, MD3; Gerhard J. Jungehulsing, MD11; Bruno-Marcel Mackert, MD12; Andreas Hartmann, MD13; Jessica L. Rohmann, MScPH1,14; Matthias Endres, MD1,4,7,8,15,16; Heinrich J. Audebert, MD1,4; for the Berlin_PRehospital Or Usual Delivery in stroke care (B_PROUD) study group
doi : 10.1001/jama.2020.26345
JAMA. 2021;325(5):454-466
Effects of thrombolysis in acute ischemic stroke are time-dependent. Ambulances that can administer thrombolysis (mobile stroke units [MSUs]) before arriving at the hospital have been shown to reduce time to treatment.
Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy
Andrés Moreno-De-Luca, MD1,2,3,4; Francisca Millan, MD5; Denis R. Pesacreta, BS1; Houda Z. Elloumi, PhD5; Matthew T. Oetjens, PhD1; Claire Teigen, MS5; Karen E. Wain, MS1,2; Julie Scuffins, MS5; Scott M. Myers, MD1; Rebecca I. Torene, PhD5; Vladimir G. Gainullin, PhD5; Kevin Arvai, MS5; H. Lester Kirchner, PhD6; David H. Ledbetter, PhD1,2; Kyle Retterer, MS5; Christa L. Martin, PhD1,2
doi : 10.1001/jama.2020.26148
JAMA. 2021;325(5):467-475
Cerebral palsy is a common neurodevelopmental disorder affecting movement and posture that often co-occurs with other neurodevelopmental disorders. Individual cases of cerebral palsy are often attributed to birth asphyxia; however, recent studies indicate that asphyxia accounts for less than 10% of cerebral palsy cases.
Screening for Asymptomatic Carotid Artery Stenosis in the General Population
Janelle M. Guirguis-Blake, MD1; Elizabeth M. Webber, MS2; Erin L. Coppola, MPH2
doi : 10.1001/jama.2020.20364
JAMA. 2021;325(5):487-489
Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From April 16 to October 12, 2020
Ruiqi Ren, MD1; Yanping Zhang, MD1; Qun Li, MD1; Jennifer M. McGoogan, PhD1; Zijian Feng, MD1; George F. Gao, DPhil1; Zunyou Wu, MD, PhD1
doi : 10.1001/jama.2020.23942
JAMA. 2021;325(5):489-492
Screening for Asymptomatic Carotid Artery Stenosis
US Preventive Services Task Force
doi : 10.1001/jama.2020.26988
JAMA. 2021;325(5):476-481
Carotid artery stenosis is atherosclerotic disease that affects extracranial carotid arteries. Asymptomatic carotid artery stenosis refers to stenosis in persons without a history of ischemic stroke, transient ischemic attack, or other neurologic symptoms referable to the carotid arteries. The prevalence of asymptomatic carotid artery stenosis is low in the general population but increases with age.
Reducing Administrative Waste in the US Health Care System
Robert P. Kocher, MD1
doi : 10.1001/jama.2020.24767
JAMA. 2021;325(5):427-428
Ensuring Quality in the Era of Virtual Care
Kurt R. Herzer, MD, PhD, MSc1; Peter J. Pronovost, MD, PhD2
doi : 10.1001/jama.2020.24955
JAMA. 2021;325(5):429-430
Paying for Telemedicine After the Pandemic
Ateev Mehrotra, MD1; R. Sacha Bhatia, MD2; Centaine L. Snoswell, PhD3
doi : 10.1001/jama.2020.25706
JAMA. 2021;325(5):431-432
Obesity Management in Women of Reproductive Age
S. Michelle Ogunwole, MD1; Chloe A. Zera, MD, MPH2; Fatima Cody Stanford, MD, MPH, MPA3,4
doi : 10.1001/jama.2020.21096
JAMA. 2021;325(5):433-434
Virtual Care, Telemedicine Visits, and Real Connection in the Era of COVID-19
Donna M. Zulman, MD, MS1,2; Abraham Verghese, MD3
doi : 10.1001/jama.2020.27304
JAMA. 2021;325(5):437-438
Economic Prosperity and Cardiovascular Mortality
William B. Weeks, MD, PhD, MBA1; James N. Weinstein, DO, MS1
doi : 10.1001/jama.2020.26717
JAMA. 2021;325(5):439-440
Improving Stroke Treatment and Outcomes With Mobile Stroke Units
Kristi G. Bache, PhD1,2; James C. Grotta, MD3
doi : 10.1001/jama.2020.25832
JAMA. 2021;325(5):441-442
Screening for Asymptomatic Carotid Artery Stenosis
Larry B. Goldstein, MD1
doi : 10.1001/jama.2020.26440
JAMA. 2021;325(5):443-444
Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy
Pankti D. Reid, MD, MPH1; Adam S. Cifu, MD1; Anne R. Bass, MD2
doi : 10.1001/jama.2020.17308
JAMA. 2021;325(5):482-483
APOE ?4 Allele Testing and Risk of Alzheimer Disease
Parichita Choudhury, MD, MSc1; Vijay K Ramanan, MD, PhD1; Bradley F. Boeve, MD1
doi : 10.1001/jama.2020.15085
JAMA. 2021;325(5):484-485
Therapists Donate Their Time to Counsel Distressed Health Care Workers
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.25689
JAMA. 2021;325(5):420-422
Adjuvant Therapy Approved for NSCLC
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.0168
JAMA. 2021;325(5):426
Tighter Requirements to Ensure Safer Opioid Prescribing
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.0050
JAMA. 2021;325(5):426
Dedicated Device Permits Less Invasive Pancreatic Surgery
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.0170
JAMA. 2021;325(5):426
Dying Poor in the US—Disparities in End-of-Life Care
Melissa W. Wachterman, MD, MPH, MSc1,2; Benjamin D. Sommers, MD, PhD3,4
doi : 10.1001/jama.2020.26162
JAMA. 2021;325(5):423-424
Autoantibodies May Drive COVID-19 Blood Clots
Tracy Hampton, PhD
doi : 10.1001/jama.2020.25699
JAMA. 2021;325(5):425
Innocence in America—Reading James Baldwin in 2020
Alok A. Khorana, MD1,2
doi : 10.1001/jama.2020.22102
JAMA. 2021;325(5):418-419
I Dream of Animals During the Pandemic
M. Cynthia Cheung, MD1
doi : 10.1001/jama.2020.22849
JAMA. 2021;325(5):495
Screening for Carotid Artery Stenosis
Jill Jin, MD, MPH1
doi : 10.1001/jama.2021.0035
JAMA. 2021;325(5):500
Determination of Brain Death
Christos Lazaridis, MD, EDIC1; L. Syd M. Johnson, PhD2
doi : 10.1001/jama.2020.23228
JAMA. 2021;325(5):492
Determination of Brain Death
Emily T. Cohen, MD1; Robert S. Hoffman, MD1
doi : 10.1001/jama.2020.23222
JAMA. 2021;325(5):492-493
Determination of Brain Death
Sérgio Brasil, MD, PhD1; Ricardo de Carvalho Nogueira, MD, PhD1; Marcelo de-Lima-Oliveira, MD, MSc1
doi : 10.1001/jama.2020.23225
JAMA. 2021;325(5):493
Determination of Brain Death
Trevor M. Bibler, PhD1; Alison Suen, PhD2
doi : 10.1001/jama.2020.23231
JAMA. 2021;325(5):493-494
Determination of Brain Death—Reply
Gene Sung, MD, MPH1; Ariane Lewis, MD2; David Greer, MD, MA3
doi : 10.1001/jama.2020.23234
JAMA. 2021;325(5):494
